Seiichi Matsuo

25.7k total citations · 2 hit papers
321 papers, 17.7k citations indexed

About

Seiichi Matsuo is a scholar working on Nephrology, Immunology and Molecular Biology. According to data from OpenAlex, Seiichi Matsuo has authored 321 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Nephrology, 62 papers in Immunology and 55 papers in Molecular Biology. Recurrent topics in Seiichi Matsuo's work include Chronic Kidney Disease and Diabetes (71 papers), Renal Diseases and Glomerulopathies (67 papers) and Dialysis and Renal Disease Management (62 papers). Seiichi Matsuo is often cited by papers focused on Chronic Kidney Disease and Diabetes (71 papers), Renal Diseases and Glomerulopathies (67 papers) and Dialysis and Renal Disease Management (62 papers). Seiichi Matsuo collaborates with scholars based in Japan, United States and United Kingdom. Seiichi Matsuo's co-authors include Enyu Imai, Yoshinari Yasuda, Masaru Horio, Akira Hishida, Kunihiro Yamagata, Kosaku Nitta, Hitoshi Yokoyama, Yasuhiko Tomino, Yukio Yuzawa and Kimio Tomita and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Seiichi Matsuo

314 papers receiving 17.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised Equations for Estimated GFR From Serum Creatinine in Japan

2009 5.1k citations Seiichi Matsuo, Yoshinari Yasuda et al. American Journal of Kidney Diseases profile →
Aspects of Immune Dysfunction in End-stage Renal Disease

2008 781 citations Sawako Kato, Seiichi Matsuo et al. profile →

Peers

Countries citing papers authored by Seiichi Matsuo

Since Specialization

Citations

This map shows the geographic impact of Seiichi Matsuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiichi Matsuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiichi Matsuo more than expected).

Fields of papers citing papers by Seiichi Matsuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiichi Matsuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiichi Matsuo. The network helps show where Seiichi Matsuo may publish in the future.

Co-authorship network of co-authors of Seiichi Matsuo

This figure shows the co-authorship network connecting the top 25 collaborators of Seiichi Matsuo. A scholar is included among the top collaborators of Seiichi Matsuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiichi Matsuo. Seiichi Matsuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health-related Quality of Life in 10 years Long-term Survivors of Chronic Kidney Disease: A From-J Study 2023 ·Journal of Renal Nutrition ·Reiko Okubo, (unknown), Toshiyuki Imasawa, Chie Saito, Hirayasu Kai, (unknown), Junichi Hoshino, Tsuyoshi Watanabe, Ichiei Narita, Seiichi Matsuo, Hirofumi Makino, Akira Hishida, Kunihiro Yamagata	1
2	Microchip Immunoassays for Monitoring Renal Function: Rapid, Low-Cost, and Highly Sensitive Quantification of Urinary Biomarkers of Diabetic Nephropathy 2021 ·Micromachines ·Toshihiro Kasama, Miaomiao Sun, Noritada Kaji, Shin‐ichi Akiyama, Yukio Yuzawa, Manabu Tokeshi, Seiichi Matsuo, Yoshinobu Baba	1
3	Association Between Reappearance of Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis 2018 ·Arthritis & Rheumatology ·Haruki Watanabe, Ken‐ei Sada, Yoshinori Matsumoto, Masayoshi Harigai, Koichi Amano, Hiroaki Dobashi, Shouichi Fujimoto, Joichi Usui, Kunihiro Yamagata, Tatsuya Atsumi, Shogo Banno, Takahiko Sugihara, Yoshihiro Arimura, Seiichi Matsuo, Hirofumi Makino	28
4	High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients 2017 ·PLoS ONE ·Masashi Mizuno, Yasuhíro Suzuki, (unknown), (unknown), (unknown), Fumiko Sakata, Masanobu Horie, Shoichi Maruyama, Seiichi Matsuo, B. Paul Morgan, Yasuhiko Ito	13
5	Association of interactions between dietary salt consumption and hypertension-susceptibility genetic polymorphisms with blood pressure among Japanese male workers 2016 ·Clinical and Experimental Nephrology ·Takahiro Imaizumi, Masahiko Ando, Masahiro Nakatochi, Shoichi Maruyama, Yoshinari Yasuda, Hiroyuki Honda, Yachiyo Kuwatsuka, Sawako Kato, Takaaki Kondo, Masamitsu Iwata, (unknown), Hiroshi Yasui, (unknown), Hiroshi Okajima, Yukiko Yoshida, Seiichi Matsuo	11
6	Transfusion of CD206+ M2 Macrophages Ameliorates Antibody-Mediated Glomerulonephritis in Mice 2016 ·American Journal Of Pathology ·Qiuna Du, Naotake Tsuboi, Yiqin Shi, Sachiko Ito, Yutaka Sugiyama, Kazuhiro Furuhashi, (unknown), Hangsoo Kim, Takayuki Katsuno, Shin‐ichi Akiyama, Seiichi Matsuo, K Isobe, Shoichi Maruyama	39
7	Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis 2012 ·Diabetologia ·Hideki Ishii, (unknown), Hiroshi Takahashi, Takanobu Toriyama, Toru Aoyama, Miho Tanaka, Daiki Yoshikawa, Mutsuharu Hayashi, Hirotake Kasuga, Yoshinari Yasuda, Shoichi Maruyama, Tatsuaki Matsubara, Seiichi Matsuo, Toyoaki Murohara	18
8	Deficiency of Growth Factor Midkine Exacerbates Necrotizing Glomerular Injuries in Progressive Glomerulonephritis 2012 ·American Journal Of Pathology ·Hiroshi Kojima, Tomoki Kosugi, Waichi Sato, Yuka Sato, Kayaho Maeda, Noritoshi Kato, (unknown), Shinichiro Inaba, Takuji Ishimoto, Naotake Tsuboi, Seiichi Matsuo, Shoichi Maruyama, Yukio Yuzawa, Kenji Kadomatsu	9
9	4. Evidence-based Clinical Practice Guidelines for CKD (2009). 2010 ·Nihon Naika Gakkai Zasshi ·Seiichi Matsuo	2
10	Zymosan, but Not Lipopolysaccharide, Triggers Severe and Progressive Peritoneal Injury Accompanied by Complement Activation in a Rat Peritonitis Model 2009 ·The Journal of Immunology ·Masashi Mizuno, Yasuhiko Ito, (unknown), Tomohiro Mizuno, Yukihiro Noda, Yukio Yuzawa, Claire L. Harris, B. Paul Morgan, Seiichi Matsuo	33
11	A murine model of neonatal diabetes mellitus in Glis3‐deficient mice 2009 ·FEBS Letters ·Naoki Watanabe, (unknown), (unknown), Kaoru Yasuda, Norihiko Suzuki, Naoko Oshima, Hiroshi Kiyonari, Dai Shiba, Saori Nishio, Toshio Mochizuki, (unknown), Shoichi Maruyama, Seiichi Matsuo, Yuko Wakamatsu, Hisashi Hashimoto	64
12	Lymphatic vessels develop during tubulointerstitial fibrosis 2009 ·Kidney International ·Izumi Sakamoto, Yasuhiko Ito, Masashi Mizuno, Yasuhíro Suzuki, (unknown), Akio Tanaka, Shoichi Maruyama, Yoshifumi Takei, Yukio Yuzawa, Seiichi Matsuo	92
13	In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency 2008 ·Molecular Cancer Therapeutics ·Yoshifumi Takei, (unknown), Ping Mu, Tatsuya Fujishima, Takuji Ishimoto, Yasuhiko Hayakawa, Yukio Yuzawa, Seiichi Matsuo, Takashi Muramatsu, Kenji Kadomatsu	31
14	Novel Culture System of Mesenchymal Stromal Cells from Human Subcutaneous Adipose Tissue 2008 ·Stem Cells and Development ·(unknown), Takenori Ozaki, Shoichi Maruyama, (unknown), Masato Kobori, Kaoru Omae, Hirotake Yamaguchi, Tomoaki Niimi, Kazuhiro Toriyama, Yuzuru Kamei, Shuhei Torii, Toyoaki Murohara, Yukio Yuzawa, Yasuo Kitagawa, Seiichi Matsuo	51
15	High Levels of Complement C3a Receptor in the Glomeruli in Lupus Nephritis 2007 ·American Journal of Kidney Diseases ·Masashi Mizuno, (unknown), Philippe Gasque, Kazuhiro Nishikawa, Seiichi Matsuo	24
16	Midkine Is Involved in Neutrophil Infiltration into the Tubulointerstitium in Ischemic Renal Injury 2001 ·The Journal of Immunology ·Waichi Sato, Kenji Kadomatsu, Yukio Yuzawa, Hisako Muramatsu, Nigishi Hotta, Seiichi Matsuo, Takashi Muramatsu	157
17	Distribution of the Receptor for AGE in normal and diabetic rats kidney 1996 ·Journal of the American Society of Nephrology ·(unknown), (unknown), Tomohiko Naruse, Nigishi Hotta, (unknown), Ann Marie Schmidt, David Stern, Seiichi Matsuo	1
18	Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. 1995 ·Journal of Clinical Investigation ·Akihiro Nomura, Kazuhiro Nishikawa, Y. Yuzawa, Hiroshi Okada, N Okada, B. Paul Morgan, Sara J. Piddlesden, (unknown), Takafumi Hasegawa, Seiichi Matsuo	68
19	In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. 1994 ·The Journal of Experimental Medicine ·Seiichi Matsuo, Shizunori Ichida, Hisao Takizawa, N Okada, Lajos Baranyi, A Iguchi, B. Paul Morgan, Hiroshi Okada	68
20	Glomerular injury induced by antibodies against heparan sulfate proteoglycan (HSPG) derived from PYS 2 cells. 1989 ·PubMed ·Futoshi Yoshida, Seiichi Matsuo, Takeyuki Hiramatsu, (unknown), Yukio Yuzawa, Yuzo Watanabe, Nobuo Sakamoto, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact